Publication | Closed Access
Olanzapine Augmentation for Treatment-Resistant Obsessive-Compulsive Disorder
109
Citations
0
References
2000
Year
Olanzapine augmentation may benefit treatment-unresponsive OCD. Double-blind, placebo-controlled trials are warranted along with trials comparing risperidone and olanzapine augmentation.